Approvals/TGA/XELJANZ XR tofacitinib (as citrate) 11 mg extended release tablet blister pack

Approved

STANDARD

XELJANZ XR tofacitinib (as citrate) 11 mg extended release tablet blister pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a16ab921646623cb
Product Name: XELJANZ XR tofacitinib (as citrate) 11 mg extended release tablet blister pack
Artg Id: 381790
Artg Name: XELJANZ XR tofacitinib (as citrate) 11 mg extended release tablet blister pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2023-01-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/8d624dad1431817fb281b032dc7acea4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a16ab921646623cb

Type

Standard